SCHEMBL30901243

SCHEMBL30901243

OC1CC2Oc3ccccc3C2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
HTR2A P28223 5/20 0.33
HTR2C P28335 5/20 0.33
GUSB P08236 4/20 0.33
HRH1 P35367 2/20 0.33
LTB4R Q15722 1/20 0.32
LTB4R2 Q9NPC1 1/20 0.32
HTR2B P41595 1/20 0.32
ADORA3 P0DMS8 1/20 0.31
AR P10275 1/20 0.31
HSD11B1 P28845 1/20 0.31
AKR1C3 P42330 1/20 0.31
ATM Q13315 1/20 0.31
ABCB1 P08183 2/20 0.30
CHRM2 P08172 1/20 0.30
CHRM4 P08173 1/20 0.30
CHRM5 P08912 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17974163 0.86 ESR1 (0.40) MAOAMAOBESR1ESR2HTR2A
SCHEMBL2338819 0.75 ATM (0.44) ESR1ESR2ATM
SCHEMBL26227708 0.72 ESR1 (0.42) MAOAMAOBESR1ESR2ATM
SCHEMBL29959448 0.72 SLC6A3 (0.39) ATM
SCHEMBL10109661 0.71 ESR1 (0.37) ESR1ESR2HTR2AHTR2CHRH1
SCHEMBL10682685 0.69 ESR1 (0.51) ESR1ESR2ABCB1
SCHEMBL9391610 0.69 ESR1 (0.47) ESR1ESR2ABCB1
SCHEMBL7317272 0.69 ESR1 (0.47) ESR1ESR2ABCB1
SCHEMBL11650198 0.69 MAOA (0.52) MAOAMAOBESR1ESR2HTR2A
SCHEMBL24925989 0.68 ESR1 (0.38) ESR1ESR2HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12497375-B2 Processes and intermediates for the preparations of benzoprostacyclin analogues and benzoprostacyclin analogues prepared therefrom CHIROGATE INTERNATIONAL INC. (TW) 2025-12-16 US disclosed
US-20240150308-A1 PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF BENZOPROSTACYCLIN ANALOGUES AND BENZOPROSTACYCLIN ANALOGUES PREPARED THEREFROM CHIROGATE INTERNATIONAL INC. (TW) 2024-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240150308-A1 PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF BENZOPROSTACYCLIN ANALOGUES AND BENZOPROSTACYCLIN ANALOGUES PREPARED THEREFROM PTGIS, PTGIR, PTGES MAOA 1320/4885MAOB 1112/4885ESR1 3506/4885
US-12497375-B2 Processes and intermediates for the preparations of benzoprostacyclin analogues and benzoprostacyclin analogues prepared therefrom PTGIS, PTGIR, PTGES MAOA 1320/4885MAOB 1112/4885ESR1 3506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.